Author/Authors :
Amore، نويسنده , , Mario and Strippoli، نويسنده , , Pierluigi and Laterza، نويسنده , , Caterina and Tagariello، نويسنده , , Pietro and Vitale، نويسنده , , Lorenza and Casadei، نويسنده , , Raffaella and Frabetti، نويسنده , , Flavia and Canaider، نويسنده , , Silvia and Lenzi، نويسنده , , Luca and DʹAddabbo، نويسنده , , Pietro and Carinci، نويسنده , , Paolo and Torroni، نويسنده , , Arianna and Ferrari، نويسنده , , Giuseppe and Zannotti، نويسنده , , Maria، نويسنده ,
Abstract :
Background: The ADARB1 gene is located in 21q22.3 region, previously linked to familial bipolar disorder, and its product has a documented action in the editing of the pre-mRNA of glutamate receptor B subunit. Dysfunction of glutamatergic neurotransmission could play an important role in the patophysiology of bipolar disorder (BD). Glutamate excitatory neurotransmission regulation is a possible mechanism of the initial effect of anticonvulsants in regulating mood. Methods: To investigate the hypothesis of an involvement of ADARB1 gene in the BD, the ADARB1 cDNA has been cloned and sequenced in seven selected bipolar I disorder patients with evidence of familiarity of mood disorders. A detailed investigation of the gene nucleotide sequence in the open reading frame has been performed. Results: No alteration in the sequence of the ADARB1 gene cDNA was found in any patient, except a common neutral polymorphism in three out of seven patients. Conclusions: Mutations in ADARB1 gene are not commonly associated with bipolar I disorder, therefore other genes in the 21q22 region could be associated with bipolar illness in some families, likely in the context of a multifactorial transmission model.
Keywords :
ADARB1 gene , bipolar disorder , sequencing , Polymorphism , glutamate , ANTICONVULSANTS